UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cost-effectiveness of taurolidine locks to prevent recurrent catheter-related blood stream infections in adult patients receiving home parenteral nutrition: a 2-year mirror-image study

Clinical nutrition (Edinburgh, Scotland), 2021-06, Vol.40 (6), p.4309-4315

2021

Volltextzugriff (PDF)

Taurolidine in Pediatric Home Parenteral Nutrition Patients

The Pediatric infectious disease journal, 2017-02, Vol.36 (2), p.233-235

2017

Volltextzugriff (PDF)

Comparing the cytotoxicity of taurolidine, mitomycin C, and oxaliplatin on the proliferation of in vitro colon carcinoma cells following pressurized intra-peritoneal aerosol chemotherapy (PIPAC)

World journal of surgical oncology, 2019-06, Vol.17 (1), p.93-7, Article 93

2019

Volltextzugriff (PDF)

Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: A heparin-controlled prospective trial

Clinical nutrition (Edinburgh, Scotland), 2010-08, Vol.29 (4), p.464-468

2010

Volltextzugriff (PDF)

Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo

BMC cancer, 2017-03, Vol.17 (1), p.216, Article 216

2017

Volltextzugriff (PDF)

Central venous catheters and catheter locks in children with cancer: A prospective randomized trial of taurolidine versus heparin

Pediatric blood & cancer, 2013-08, Vol.60 (8), p.1292-1298

2013

Volltextzugriff (PDF)

Prevention of dialysis catheter-related sepsis with a citrate–taurolidine-containing lock solution

Nephrology, dialysis, transplantation, 2004-06, Vol.19 (6), p.1546-1551

2004

Volltextzugriff (PDF)

Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT)

Trials, 2018-05, Vol.19 (1), p.264-264, Article 264

2018

Volltextzugriff (PDF)

Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2012-10, Vol.120 (10), p.794-801

2012

Volltextzugriff (PDF)

Taurolidine lock: The key to prevention of recurrent catheter-related bloodstream infections

Clinical nutrition (Edinburgh, Scotland), 2005-06, Vol.24 (3), p.462-465

2005

Volltextzugriff (PDF)

TRAIL and Taurolidine Enhance the Anticancer Activity of Doxorubicin, Trabectedin and Mafosfamide in HT1080 Human Fibrosarcoma Cells

Anticancer research, 2012-07, Vol.32 (7), p.2967-2984

2012

Volltextzugriff (PDF)

Taurolidine induces epithelial-mesenchymal transition via up-regulation of the transcription factor Snail in human pancreatic cancer cell lines

International journal of colorectal disease, 2014-11, Vol.29 (11), p.1339-1348

2014

Volltextzugriff (PDF)

Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma

Journal of experimental & clinical cancer research, 2013-10, Vol.32 (1), p.74-74, Article 74

2013

Volltextzugriff (PDF)

The Pharmacokinetics of Taurolidine Metabolites in Healthy Volunteers

Journal of clinical pharmacology, 2007-06, Vol.47 (6), p.697-703

2007

Volltextzugriff (PDF)

Intra-Abdominal Use of Taurolidine or Heparin as Alternative Products to an Antiadhesive Barrier (Seprafilm®) in Adhesion Prevention: An Experimental Study on Mice

Diseases of the colon & rectum, 2007-12, Vol.50 (12), p.2209-2214

2007

Volltextzugriff (PDF)

The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitro

BMC veterinary research, 2013-01, Vol.9 (1), p.15-15, Article 15

2013

Volltextzugriff (PDF)

A NEW HAEMODIALYSIS CATHETER-LOCKING AGENT REDUCES INFECTIONS IN HAEMODIALYSIS PATIENTS

Journal of renal care, 2008-09, Vol.34 (3), p.116-120

2008

Volltextzugriff (PDF)

Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis

Clinical nephrology, 2011-01, Vol.75 (1), p.70

2011

Volltextzugriff (PDF)

Taurolidine: A New Alternative Agent for the Management of the Postoperative Air Leak

Annals of Thoracic and Cardiovascular Surgery, 2013/02/20, Vol.19(1), pp.6-11

2013

Volltextzugriff (PDF)

Descending mediastinitis managed by sternotomy, taurolidine and delayed closure

Asian cardiovascular & thoracic annals, 2013-10, Vol.21 (5), p.612-614

2013

Volltextzugriff (PDF)

Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer

Cancer chemotherapy and pharmacology, 2004-09, Vol.54 (3), p.249-258

2004

Volltextzugriff (PDF)

High Doses of Taurolidine Inhibit Advanced Intraperitoneal Tumor Growth in Rats

The Journal of surgical research, 2005-11, Vol.129 (1), p.129-135

2005

Volltextzugriff (PDF)

Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in rats

Surgical endoscopy, 2005-02, Vol.19 (2), p.280-284

2005

Volltextzugriff (PDF)

Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats

Clinical & experimental metastasis, 2005-01, Vol.22 (1), p.77-83

2005

Volltextzugriff (PDF)

Leukopoiesis is not affected after intravenous treatment with the novel antineoplastic agent taurolidine. Results of an experimental study in rats

European surgical research, 2008-05, Vol.40 (4), p.341

2008

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

ThemaThiadiazines - Administration & Dosage

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Thema

Taurine - Administration & Dosage
(30)
Taurine - Analogs & Derivatives
(30)
Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Taurolidine
(27)
Humans
(21)
Male
(20)
Animals
(15)
Antineoplastic Agents - Administration & Dosage
(14)
Biological And Medical Sciences
(12)
Medical Sciences
(11)
Female
(9)
Oncology
(9)
Adult
(8)
Cell Line, Tumor
(8)
Rats
(8)
Surgery
(8)
Heparin - Administration & Dosage
(7)
Middle Aged
(7)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cost-effectiveness of taurolidine locks to prevent recurrent catheter-related blood stream infections in adult patients receiving home parenteral nutrition: a 2-year mirror-image study

Taurolidine in Pediatric Home Parenteral Nutrition Patients

Comparing the cytotoxicity of taurolidine, mitomycin C, and oxaliplatin on the proliferation of in vitro colon carcinoma cells following pressurized intra-peritoneal aerosol chemotherapy (PIPAC)

Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: A heparin-controlled prospective trial

Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo

Central venous catheters and catheter locks in children with cancer: A prospective randomized trial of taurolidine versus heparin

Prevention of dialysis catheter-related sepsis with a citrate–taurolidine-containing lock solution

Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT)

Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin

Taurolidine lock: The key to prevention of recurrent catheter-related bloodstream infections

TRAIL and Taurolidine Enhance the Anticancer Activity of Doxorubicin, Trabectedin and Mafosfamide in HT1080 Human Fibrosarcoma Cells

Taurolidine induces epithelial-mesenchymal transition via up-regulation of the transcription factor Snail in human pancreatic cancer cell lines

Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma

The Pharmacokinetics of Taurolidine Metabolites in Healthy Volunteers

Intra-Abdominal Use of Taurolidine or Heparin as Alternative Products to an Antiadhesive Barrier (Seprafilm®) in Adhesion Prevention: An Experimental Study on Mice

The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitro

A NEW HAEMODIALYSIS CATHETER-LOCKING AGENT REDUCES INFECTIONS IN HAEMODIALYSIS PATIENTS

Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis

Taurolidine: A New Alternative Agent for the Management of the Postoperative Air Leak

Descending mediastinitis managed by sternotomy, taurolidine and delayed closure

Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer

High Doses of Taurolidine Inhibit Advanced Intraperitoneal Tumor Growth in Rats

Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in rats

Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats

Leukopoiesis is not affected after intravenous treatment with the novel antineoplastic agent taurolidine. Results of an experimental study in rats

Aktive Filter

Suchergebnisse filtern